Oakes D J, Ritchie H E, Woodman P D C, Narup E, Moscova M, Picker K, Webster W S
Discipline of Biomedical Science (Lidcombe Campus), Faculty of Medicine, University of Sydney, 75 East Street, Lidcombe. NSW 2141, Australia.
Toxicol Ind Health. 2009 Feb;25(1):5-13. doi: 10.1177/0748233709103037.
The Royal Australian Air Force (RAAF) has reported that personnel involved in F-111 fuel tank maintenance were concerned that exposure to a range of chemicals during the period 1977 to mid-1990s was the cause of health problems, including cancer. Particular concern was directed at SR-51, a desealant chemical mixture containing the following four solvents: aromatic 150 solvent (Aro150), dimethylacetamide, thiophenol (TP), and triethylphosphate. The present study examined the mutagenic potential of SR-51 using a range of well-known mutagen and genotoxin assays. The tests used were i) a modified version of the Ames test, ii) the mouse lymphoma assay, iii) the comet assay (a single-cell gel electrophoresis assay), and iv) a mouse micronucleus test. The modified Ames test used mixed bacterial strains in liquid suspension media. The Ames test results showed that SR-51 (tested up to the cytotoxic concentration of 36 microg/ml, 30 min incubation) in the presence and absence of S9 metabolic activation was not mutagenic. The mouse lymphoma assay used cultured mouse lymphoma cells in a microwell suspension method. The mouse lymphoma assay was also negative with SR-51 (tested up to the cytotoxic concentration of 22.5 microg/ml, 3 h incubation) in the presence and absence of S9 metabolic activation. The Comet assay, using cultured mouse lymphoma cells, showed no evidence of DNA damage in cells exposed up to the cytotoxic concentration of SR-51 at 11.25 microg/ml. The in-vivo mouse micronucleus test was undertaken in wild-type C57Bl6J male mice dosed orally with SR-51for 14 days with a single daily dose up to 360 mg/kg/day (the maximum-tolerated dose). No increases were observed in micronuclei (MN) frequency in bone marrow collected (24 h after final dose) from SR-51-treated mice compared to the number of MN observed in bone marrow collected from untreated mice. Tissues collected from treated mice at necropsy demonstrated a significant increase in spleen weights in the high dose mice. Gas chromatography analysis of SR-51 identified more than 40 individual components and an oxidation product, diphenyldisulfide derived from TP under conditions of mild heating. In conclusion, there was no evidence that SR-51 is mutagenic.
澳大利亚皇家空军(RAAF)报告称,参与F - 111燃油箱维护的人员担心,在1977年至20世纪90年代中期接触一系列化学物质是导致包括癌症在内的健康问题的原因。特别令人担忧的是SR - 51,一种含有以下四种溶剂的脱漆剂化学混合物:芳烃150溶剂(Aro150)、二甲基乙酰胺、苯硫酚(TP)和磷酸三乙酯。本研究使用一系列知名的诱变剂和基因毒素检测方法,检测了SR - 51的诱变潜力。所使用的检测方法包括:i)改良版的艾姆斯试验;ii)小鼠淋巴瘤试验;iii)彗星试验(单细胞凝胶电泳试验);iv)小鼠微核试验。改良的艾姆斯试验在液体悬浮培养基中使用混合细菌菌株。艾姆斯试验结果表明,在有和没有S9代谢激活的情况下,SR - 51(检测至细胞毒性浓度36微克/毫升,孵育30分钟)均无致突变性。小鼠淋巴瘤试验采用微孔悬浮法培养小鼠淋巴瘤细胞。在有和没有S9代谢激活的情况下,SR - 51(检测至细胞毒性浓度22.5微克/毫升,孵育3小时)的小鼠淋巴瘤试验结果也为阴性。使用培养的小鼠淋巴瘤细胞进行的彗星试验表明,暴露于细胞毒性浓度达11.25微克/毫升的SR - 51的细胞中,没有DNA损伤的证据。体内小鼠微核试验在野生型C57Bl6J雄性小鼠中进行,口服给予SR - 51,连续14天,每日单次剂量最高达360毫克/千克/天(最大耐受剂量)。与未处理小鼠骨髓中观察到的微核数量相比,在接受SR - 51处理的小鼠(末次给药后24小时)采集的骨髓中,微核(MN)频率没有增加。在尸检时从处理过的小鼠身上采集的组织显示,高剂量小鼠的脾脏重量显著增加。对SR - 51的气相色谱分析确定了40多种单独成分以及一种氧化产物,即在温和加热条件下由TP衍生而来的二苯基二硫化物。总之,没有证据表明SR - 51具有致突变性。